RXI PHARMACEUTICALS CORP Chart calendar RXi Pharmaceuticals Corp
e4ae29b7d6a7e4858d38e210.d1gYGOd50_LfTtza0Jie5_ZNG6v8aiFio7lsErM8e5o.OgxNUp0qm56JfrGQod2ut588VtmSHnAM0PEiZdl4TutEMk97tkiqo7ILmQ~086a79bcb32addea5f27e6b135f6400a
Upcoming events on RXi Pharmaceuticals Corp
Past events on RXi Pharmaceuticals Corp
| 2024-05-16 05:30 pm | Society for Investigative Dermatology Meeting - Abstract No: 283 |
| 2024-05-16 05:30 pm | Society for Investigative Dermatology Meeting - Abstract No: 576 |
| 2024-05-16 05:30 pm | Society for Investigative Dermatology Meeting - Abstract No: 575 |
| 2024-05-09 05:25 pm | Q1 2024 Earnings Release |
| 2024-05-08 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract Number:774 |
| 2024-04-02 07:30 am | Q4 2023 Earnings Release |
| 2024-03-22 01:00 pm | Immunotherapy of Cancer Conference |
| 2024-03-21 01:00 pm | Immunotherapy of Cancer Conference |
| 2024-03-21 01:00 pm | Immunotherapy of Cancer Conference - Poster No : P01.03 |
| 2023-11-09 04:30 pm | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 474 |
| 2023-10-14 12:30 pm | AACR NCI EORTC International Conference - INTASYL™ self-delivering RNAi therapeutic targeting BRD4 e |
| 2023-10-14 12:30 pm | AACR NCI EORTC International Conference - INTASYL™ PH-894 self-delivering RNAi targeting BRD4 |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-10 04:30 pm | Q2 2023 Earnings Release |
| 2023-07-20 09:00 am | Annual General Meeting |
| 2023-05-17 03:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No: 544 |
| 2023-05-11 05:00 pm | Q1 2023 Earnings Release |
| 2023-04-18 01:30 pm | American Association for Cancer Research Meeting |
| 2023-04-17 09:00 am | American Association for Cancer Research Meeting - Intratumoral PH-762 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,02 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,99 -8,60 -4.5% | -8,79 -8,80 0.08% | -13,5 -14,4 6.17% | -11,5 -12,4 7.56% | -10,8 -12,0 9.8% | -9,60 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -9,60 |
|
Net income Million USD | Released Forecast Spread | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -10,8 -12,0 9.78% | -9,60 |
|
EPS USD | Released Forecast Spread | -232 -224 -3.37% | -23,0 -23,0 0% | -12,5 -13,3 6.31% | -10,1 -10,9 7.51% | -5,20 -6,26 16.93% | -1,82 |
| Announcement Date | 26/03/20 | 25/03/21 | 22/03/22 | 22/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 12,5 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | ||
|
EBIT Million USD | Released Forecast Spread | -2,64 -4,10 35.61% | -2,52 -4,10 38.51% | -3,57 9,90 -136.07% | -2,73 -3,70 26.22% | -2,78 -2,80 0.86% | -1,90 -3,10 38.74% | -2,30 | -2,50 | -2,60 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 9,90 -136.12% | -2,73 -3,70 26.19% | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% | -2,30 | -2,50 | -2,60 | ||
|
Net income Million USD | Released Forecast Spread | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 7,50 -147.68% | -2,73 -3,70 26.19% | -2,55 | -2,78 -2,80 0.71% | -1,90 -3,10 38.87% | -2,15 | -2,30 | -2,50 | -2,60 |
|
EPS USD | Released Forecast Spread | -2,28 -3,60 36.67% | -2,28 -3,72 38.71% | -3,12 4,32 -172.22% | -2,42 -3,24 25.31% | -1,47 | -1,14 -1,43 20.28% | -0,17 -1,30 86.92% | -0,47 | -0,51 | -0,46 | -0,40 |
| Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 10/08/23 | 09/11/23 | 01/04/24 | 09/05/24 | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for RXi Pharmaceuticals Corp
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
